Real-time AI-powered analysis for UNH with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
Free summary — full analysis below.
UnitedHealth Group Incorporated
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 9, 10:12 AM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Pullback in Uptrend — Below SMA50 but above SMA200
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-90.67 (-19.6%) from high
Day's Range: $368.50 – $376.45
+$114.98 (+44.9%) above low
▼ Below — short-term downtrend (bearish)
▲ Above — long-term uptrend (bullish)
✓ 1.4x avg — normal activity, signals are reliable
✓ Normal — healthy trading conditions
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
UnitedHealth Group is currently viewed as a bargain by market analysts ahead of its upcoming Q3 earnings report. Strong investor interest and favorable valuation metrics suggest potential upside for the stock in the near term.

UnitedHealth Group (UNH) Registers a Bigger Fall Than the Market: Important Facts to Note

CVS Health Trades at a Discount to Industry: How to Play the Stock?

Dear UnitedHealth Stock Fans, Mark Your Calendars for October 13

At 73, UnitedHealthcare Will End Her Medicare Advantage Plan for 2027. If She Ignores the Letter, She’ll Wake Up January 1 With Original Medicare, No Drug Plan and No Medigap

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
Our AI engine analyzes UNH across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
The analysis calculates optimal entry and exit price targets for UNH using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
RSI measures whether UNH is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
We track institutional positioning in UNH through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
Key risks for UNH include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
The UNH analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.